Original articleFive-year results of laparoscopic sleeve gastrectomy
Section snippets
Patients and methods
In our institution, LSG as a stand-alone bariatric procedure was initially established in the context of a prospective study. Inclusion criteria were relative contraindications for LRYGB (i.e., huge abdominal hernia or history of extensive abdominal surgery), super-obesity (allowing for the possibility of expansion into a more aggressive option, such as BPD/DS), or a history of failed laparoscopic adjustable gastric banding (LAGB) (instead of BPD/DS, which until then was the first choice of a
Patient characteristics
In 41 patients, LSG was performed as a primary obesity surgical procedure (group 1), and 27 patients received LSG as secondary treatment after failed gastric banding (group 2). Regarding patient characteristics, such as weight, body mass index, and age, the 2 groups had similar starting values (Table 1).
In group 2, reasons to convert to a second bariatric intervention were band intolerance (chronic reflux symptoms and/or intolerance for certain nutrients without radiologic signs for pouch
Discussion
This is a small but well-documented series on LSG as a stand-alone procedure as primary and redo bariatric procedure with a 5-year follow-up rate of 91%. The trial was designed in the context of a pilot study more than 9 years ago. In the mean time, we could improve and standardize the operative technique, which led to even better mid-term results [13].
Although sleeve gastrectomy was initially only carried out as the first part of a 2-step procedure, we could show that a rather small percentage
Conclusions
LSG was effective 5.9 years postoperatively with an EBMIL of almost 60% and a considerable improvement or even remission of co-morbidities.
Disclosures
Markus Gass received an honorarium from Ethicon Endo-Surgery Europe, GmbH, as a hands-on workshop instructor. Ralph Peterli received an honorarium and a consulting fee from Ethicon Endo-Surgery Europe, GmbH, as a speaker and instructor for workshops, as well as a research grant as the principal investigator. The other authors have no commercial associations that might be a conflict of interest in relation to this article.
Acknowledgments
The authors thank P. Hendrickson and B. Wölnerhanssen for carefully reading the manuscript and for data management.
References (27)
- et al.
Early experience with two-stage laparoscopic Roux-en-Y gastric bypass as an alternative in the super-super obese patient
Obes Surg
(2003) - et al.
Laparoscopic sleeve gastrectomy as an isolated bariatric procedure: intermediate-term results from a large series in three Austrian centers
Obes Surg
(2008) - et al.
Weight loss, appetite suppression, and changes in fasting and postprandial ghrelin and peptide-YY levels after Roux-en-Y gastric bypass and sleeve gastrectomy: a prospective, double blind study
Ann Surg
(2008) - et al.
Sleeve gastrectomy—a "food limiting" operation
Obes Surg
(2008) - et al.
Sleeve gastrectomy and gastric banding: effects on plasma ghrelin levels
Obes Surg
(2005) - et al.
Midterm results of primary vs. secondary laparoscopic sleeve gastrectomy (LSG) as an isolated operation
Obes Surg
(2009) - et al.
Metabolic and hormonal changes after laparoscopic Roux-en-Y gastric bypass and sleeve gastrectomy: a randomized, prospective trial
Obes Surg
(2012) - et al.
Effects of postbariatric surgery weight loss on adipokines and metabolic parameters: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy—a prospective randomized trial
Surg Obes Relat Dis
(2011) - et al.
Laparoscopic sleeve gastrectomy as a single-stage bariatric procedure
Obes Surg
(2010) - et al.
Laparoscopic sleeve gastrectomy feasible for bariatric revision surgery
Obes Surg
(2012)